Upgrade to SI Premium - Free Trial

Celgene's (CELG) Otezla Receives FDA Orphan Status for Treatment of Pediatric Patients with UC

January 18, 2018 3:04 PM
Celgene's (NASDAQ: CELG) Otezla received FDA orphan drug designation for treatment of pediatric patients with ulcerative ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles